Cardiac Surgery
Cohort Study: Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm
13 Apr, 2021 | 05:05h | UTCRelated: Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms (study and commentaries) AND Link between fluoroquinolones, aorta problems may not be as strong as thought AND Study: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation AND FDA Warns About Increased Risk of Aortic Dissection and Ruptures of Aortic Aneurism with Fluoroquinolones AND Meta-analysis: Fluoroquinolones and the Risk of Aortopathy AND Study: Oral Fluoroquinolone and the Risk of Aortic Dissection AND Research: Fluoroquinolone use and risk of aortic aneurysm and dissection
Controversies in revascularization for stable coronary artery disease
30 Mar, 2021 | 02:49h | UTCControversies in revascularisation for stable coronary artery disease – Clinical Medicine Journal
Long-term outcomes of patients undergoing the Ross procedure
21 Mar, 2021 | 21:42h | UTCCommentaries: Ross Procedure Done Well Holds Up Over Time – TCTMD AND Long-Term Outcomes of the Ross Procedure – American College of Cardiology
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
23 Mar, 2021 | 02:33h | UTCSARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery – Anaesthesia
Commentary on Twitter
Our research has underpinned key recommendations in new guidance on SARS-CoV-2 infection & elective surgery from @Assoc_Anaes & @RCoANews & @RCSnews.
This guideline can act as a template for policy makers in other countries!
🆓https://t.co/kKgJXFf0vd pic.twitter.com/mJRasJTJws
— COVIDSurg (@CovidSurg) March 20, 2021
Platelet tests pre-CABG may safely shorten washout waits, cut costs
16 Mar, 2021 | 01:44h | UTCPlatelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs – TCTMD
M-A: Angiographic Patency of Coronary Artery Bypass Conduits
12 Mar, 2021 | 08:10h | UTC
Prevalence of bicuspid aortic valve and associated aortopathy in newborns in Copenhagen, Denmark
21 Feb, 2021 | 21:58h | UTCPrevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, Denmark – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
In this population epi study the prevalence of bicuspid aortic valve (BAV) among newborns in Copenhagen was 0.77%; aortopathy incl. coarctation was common, suggesting that it represents a fetal malformation https://t.co/xqUBzQn9NA @HenningBundgaa1 @jamapediatrics
— JAMA (@JAMA_current) February 11, 2021
Expert consensus of data elements for collection for enhanced recovery after cardiac surgery
21 Feb, 2021 | 21:53h | UTCRelated: Enhanced Recovery After Surgery (ERAS) Guidelines for Perioperative Care in Cardiac Surgery (guideline and commentary) AND Enhanced Recovery After Cardiac Surgery (ERAS Cardiac) Recommendations: An Important First Step—But There Is Much Work to Be Done – Cardiothoracic and Vascular Anesthesia (free)
See also: Enhanced Recovery After Surgery (ERAS) Society Guidelines
Commentary on Twitter
Just published in @WorldJSurg
"Expert Consensus of Data Elements for Collection for Enhanced Recovery After Cardiac Surgery"
Available for free download here https://t.co/7L4evdqg0G pic.twitter.com/3XyKt6P6wv
— ERAS Society (@ErasSociety) February 21, 2021
European position paper on the management of patients with patent foramen ovale. Part II – Decompression sickness, migraine, arterial deoxygenation syndromes, and select high-risk clinical conditions
18 Feb, 2021 | 02:36h | UTC
Observational study suggests aspirin is a better choice than warfarin for children who have undergone Fontan surgery
16 Feb, 2021 | 02:03h | UTCCommentary: Aspirin preferred to prevent blood clots in kids after heart surgery – Murdoch Children’s Research Institute
Commentary on Twitter
I have been blown away with the interest in my paper – Asprin vs warfarin after Fontan surgery ❤️3 commentaries so far, highlighting the strengths of our work and advocating for more research in this growing population @MCRI_for_kids @UniMelbMDHS @nhmrc https://t.co/nveDaqM6r3
— Dr Chantal Attard (@Chantal_Attard) February 4, 2021
RCT: Dobutamine-sparing vs. dobutamine-to-all strategy in cardiac surgery
9 Feb, 2021 | 00:57h | UTC
Randomized trial: Conservative fluid management strategy vs. usual care in participants after cardiac surgery
1 Feb, 2021 | 01:39h | UTC
Randomized trial: Continuous postoperative pericardial flushing reduces postoperative bleeding after coronary artery bypass grafting
29 Jan, 2021 | 01:28h | UTC
Meta-analysis: Minimally invasive surgery versus transcatheter aortic valve replacement
27 Jan, 2021 | 01:00h | UTCCommentary: TAVI vs Minimally Invasive AVR Yields Surprising Findings: Meta-analysis – TCTMD
Commentary on Twitter
Comprehensive systematic review and meta-analysis of miniAVR vs #TAVR. Important in the context of 'lifetime management of valves'. Thank you for the opportunity. @Shoukmed @ahmedsayed8991 @BrighamSurgery @BrighamThoracic CC:@TSRA_official @STS_CTsurgery @AATSED @ThoracicsCanada https://t.co/T1XDrebl8U pic.twitter.com/5E5eOLherA
— Sameer Hirji (@Hirji1987) January 21, 2021
Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms
12 Jan, 2021 | 01:38h | UTCAssociation of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm – JAMA Surgery (free for a limited period)
Commentaries: Fluoroquinolones and Aortic Disease—Is It Time to Broaden the Warning? – JAMA (free for a limited period) AND Study links fluoroquinolones to higher risk of aneurysm – CIDRAP AND Analysis Links Fluoroquinolones to Increased Aortic Aneurysm Risk – Physician’s Weekly
2020 ACC/AHA Guideline for the management of patients with valvular heart disease
18 Dec, 2020 | 09:45h | UTCNews release: Updated guideline for heart valve disease spotlights less invasive treatments
Key Perspectives: Part 1
Key Perspectives: Part 2
Key Perspectives: Part 3
Commentary on Twitter
New ACC/@American_Heart Guideline for the Management of patients with #cvVHD includes expanded treatment options; recommends less invasive interventions, when possible; and stresses the importance of #SharedDecisionMaking. Read it in #JACC: https://t.co/g9RE9buXNC pic.twitter.com/jnwt8d5QC7
— JACC Journals (@JACCJournals) December 17, 2020
Review: Mechanical complications of acute myocardial infarction
11 Dec, 2020 | 09:19h | UTCMechanical Complications of Acute Myocardial Infarction: A Review – JAMA Cardiology
Videos: Acute Rupture of Left Ventricular Aneurysm AND Ventricular Septal Rupture AND Papillary Muscle Rupture
Review: Perioperative venous thromboembolism prophylaxis
3 Dec, 2020 | 08:28h | UTCPerioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
#AHA20 – Randomized trial: In patients with atrial fibrillation and a bioprosthetic mitral valve, Rivaroxaban (20 mg) was noninferior to Warfarin (INR 2-3) for death, MACE, or major bleeding at 12 months
16 Nov, 2020 | 02:01h | UTCRivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Rivaroxaban may be as effective as warfarin for bioprosthetic mitral valves, AF – American Heart Association
Commentaries: Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib – TCTMD AND Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation – RIVER – American College of Cardiology AND Rivaroxaban Noninferior to Warfarin for Atrial Fibrillation in Patients with Bioprosthetic Mitral Valves – NEJM Journal Watch
Commentary on Twitter
In a trial comparing rivaroxaban with dose-adjusted warfarin, rivaroxaban was noninferior to warfarin with respect to the mean time until the primary outcome of death, major cardiovascular events, or major bleeding at 12 months. #AHA20
— NEJM (@NEJM) November 14, 2020
Safe surgery: A cluster randomized trial showed that the implementation of control charts with feedback on indicators to surgical teams was associated with concomitant reductions in major adverse events in patients
9 Nov, 2020 | 01:23h | UTC
JACC Review: Evaluation and management of patients with stable angina. Based on large clinical trials, medical therapy rather than revascularization is the initial management strategy for most patients
6 Nov, 2020 | 09:43h | UTCEvaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review – Journal of the American College of Cardiology (free for a limited period)
Summary: Evaluation and Management of Patients With Stable Angina – American College of Cardiology
Association between industry payments to physicians and device selection in ICD implantation
4 Nov, 2020 | 09:40h | UTCAssociation Between Industry Payments to Physicians and Device Selection in ICD Implantation – JAMA (free for a limited period)
Editorial: Reconsidering Health Care Fraud and Abuse Laws (free for a limited period)
Commentary on Twitter
More evidence that payments from industry to physicians influence clinical decisions. Great paper led by @AmarMD99 in @YaleCardiology shows that patients most likely to receive ICD/CRD made by manufacturer that provided largest payments to their physician https://t.co/P1Hh2VAxur
— Joseph Ross (@jsross119) November 3, 2020
Review: Management of common postoperative complications
4 Nov, 2020 | 09:26h | UTCManagement of Common Postoperative Complications – Mayo Clinic Proceedings
The ‘Ten Commandments’ in the new ESC Adult Congenital Heart Disease Guidelines
29 Oct, 2020 | 08:59h | UTCOriginal guideline and commentaries: 2020 ESC Guidelines for the management of adult congenital heart disease
[Abstract Only] Redevelopment and validation of the SYNTAX score II to predict the benefit of PCI vs. CABG in patients with complex coronary artery disease
23 Oct, 2020 | 08:59h | UTCSee calculator: SYNTAX Score II calculator